首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Therapeutic Advances In Neurological Disorders

Therapeutic Advances In Neurological Disorders杂志,由SAGE Publications Inc.出版,于2008年创刊,Continuous publication,出版语言English,ISSN:1756-2856,E-ISSN:1756-2864。

投稿咨询
Therapeutic Advances In Neurological Disorders
Therapeutic Advances In Neurological Disorders
Therapeutic Advances In Neurological Disorders
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
4
CiteScore
6.1
期刊收录
SCI、SCIE

Therapeutic Advances In Neurological Disorders(中文译名:《神经系统疾病的治疗进展》),ISSN:1756-2856,EISSN:1756-2864,是SAGE Publications Inc.出版的国际性学术期刊,创刊于2008年,以Continuous publication形式稳定发行,2026年总发文量约128篇。该刊采用OA开放访问,学科归属为CLINICAL NEUROLOGY。该刊是医学、临床神经病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4,2025年期刊CiteScore为6.1,2025年期刊自引率约5%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Therapeutic Advances In Neurological Disorders长期聚焦医学、临床神经病学及相关产业的技术应用前沿,平均审稿周期15 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、临床神经病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,GERMANY (FED REP GER)USA、Italy、CHINA MAINLAND、Switzerland、England、Spain等为核心发文国家与地区;RUHR UNIVERSITY BOCHUMNATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS、UNIVERSITY OF DUISBURG ESSEN、UNIVERSITY OF LONDON、UNIVERSITY OF TEXAS SYSTEM、UNIVERSITY OF BERN、UNIVERSITY OF MUNSTER等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
CLINICAL NEUROLOGY 临床神经病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
CLINICAL NEUROLOGY 临床神经病学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
CLINICAL NEUROLOGY 临床神经病学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 68 / 296

77.2

学科:CLINICAL NEUROLOGY SCIE Q1 67 / 296

77.53

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 41 / 277

85.4

学科:CLINICAL NEUROLOGY SCIE Q1 41 / 278

85.43


中国学者近期发文

1
Preliminary observations on the efficacy of efgartigimod in anti-LGI1-associated autoimmune encephaliti

Author:Zuo, Jing-Wen; Dai, Ying-Yue; Liu, Wen-Jing; Zhang, Jia-Ying; Shao, Xiao-Qiu; Wang, Qun; Lv, Rui-Juan

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261437004

2
Brivaracetam monotherapy in juvenile myoclonic epilepsy: a safety and efficacy evaluatio

Author:Zuo, Jing-Wen; Dai, Ying-Yue; Liu, Wen-Jing; Zhang, Jia-Ying; Shao, Xiao-Qiu; Wang, Qun; Lv, Rui-Juan

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261440217

3
Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case serie

Author:Huang, Ying; Xiong, Yihan; Zhan, Hui; Wu, Futian; Jiang, Yichun; Zhang, Yaqing; Chen, Jiaxun; Zeng, Silin; Zhang, Ting; Xiong, Xiaofeng; Chen, Zhuomin; Yang, Fang; Li, Gang; Xu, Qianhui

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261425088

4
Objective tremor monitoring using tri-axis accelerometer in MRgFUS thalamotomy for essential tremor: a feasibility stud

Author:Liu, Kai-Chun; Macerollo, Antonella; Heng, Hoon-Ming; Chen, Pei-Chiang; Lu, Ming-Kuei; Chen, Chun Ming; Tsai, Chon-Haw; Chen, Jui-Cheng

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864251406534

5
Association of atherogenic index of plasma and post-stroke epilepsy in patients with ischemic stroke: a multicenter retrospective study in Chin

Author:Wan, Xichen; Xiong, Ye; Wang, Peng; Wang, Maoqi; Huang, Lianghua; Tang, Yunliang

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261416789

6
Thymectomy with or without maintenance therapy for myasthenia gravis patients: a tri-center, real-world stud

Author:Zhang, Hao; Fan, Moli; Shi, Yutong; Huang, Xiaoyu; Cui, Ying; Yu, Zihao; Yang, Chun-Sheng; Li, Hui-Ning; Zhang, Xiao-He; Liu, Peng; Wu, Ti; Shi, Fu-Dong; Qi, Guo-Yan

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261415757

7
Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safet

Author:Bi, Zhuajin; Ye, Xiaodong; Liu, Peidong; Lu, Mengcao; Liu, Hongbo; Chen, Min

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261419026

8
Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective stud

Author:Zhou, Qian; Ouyang, Yuzhen; Jiang, Fei; Zeng, Qiuming; He, Ting; Wen, Zeyi; Shi, Guanzhong; Dong, Xiaohua; Cai, Haobing; Xiang, Wei; Su, Miao; Li, Kailin; Yang, Huan

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864261421717

9
Comprehensive versus thrombectomy-capable stroke centers: a web-based model to predict outcomes after mechanical thrombectom

Author:Gan, Shujuan; Huang, Weifeng; Yi, Tingyu; Zhang, Wenli; Lu, Xiongwei; Chen, Zhiting; Miao, Jinfeng; Wu, Yanmin; Wu, Meihua; Li, Caixia; Yang, Yining; Ye, Jinhua; Chen, Huanghuang; Wu, Ying; Zhuang, Xiaona; Xu, Yuxin; Jiao, Liqun; Chen, Wenhuo

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864251411020

10
Comorbidity and modifiable risk factors in multiple sclerosi

Author:Zhang, Yao; Dobson, Ruth; Giovannoni, Gavin

Journal: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2026; Vol. 19, Issue , pp. -. DOI: 10.1177/17562864251404455


在线咨询

Therapeutic Advances In Neurological Disorders

国际简称:THER ADV NEUROL DISO参考译名:神经系统疾病的治疗进展

年发文量:128 CiteScore:6.1 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:78.91%

杂志社联系方式:SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Therapeutic Advances In Neurological Disorders